|
Index of reports
> Cases resulting in hospitalization (23)
Below is the selection of adverse event reports related to Allegra (Fexofenadine) that includes cases resulting in hospitalization.
Adverse event in female receiving Allegra (Fexofenadine)
Reported by a physician from Japan on 2007-10-24
Patient: female, weighing 50.0 kg (110.0 pounds)
Adverse reactions / side effects: Asthma, Blood Creatine Phosphokinase Increased, Cardiac Failure, Blood Creatinine Increased
Adverse event resulted in: hospitalization
Suspect drug(s):
Crestor
Administration route: Oral
Indication: Hyperlipidaemia
Start date: 2007-05-31
End date: 2007-06-14
Relifen
Administration route: Oral
Start date: 2006-12-01
Allegra
Administration route: Oral
Start date: 2007-05-31
End date: 2007-06-19
Spiriva
Indication: Bronchitis Chronic
Start date: 2007-05-31
Other drugs received by patient: Almeta; Aldactone; Famotidine; SM; Elieten; Lasix; Gosha-Jinki-GAN; Acardi; Solon; NU-Lotan; Bezatol SR; Uralyt-U; Restamin; Transamin; Hustagin; Meiact; Mohrus Tape; Urepearl; Nitropen; Buscopan; Epadel S; Frandol S; Antibiotic Preparations Acting Mainly ON Gram Positive BA
Adverse event in female receiving Allegra (Fexofenadine)
Reported by a physician from Japan on 2007-10-10
Patient: female, weighing 50.0 kg (110.0 pounds)
Adverse reactions / side effects: Asthma, Blood Creatine Phosphokinase Increased, Chest Discomfort, Cardiac Failure, Blood Creatinine Increased
Adverse event resulted in: hospitalization
Suspect drug(s):
Crestor
Administration route: Oral
Indication: Hyperlipidaemia
Start date: 2007-05-31
End date: 2007-06-14
Relifen
Administration route: Oral
Start date: 2006-12-01
Allegra
Administration route: Oral
Start date: 2007-05-31
End date: 2007-06-19
Spiriva
Indication: Bronchitis Chronic
Start date: 2007-05-31
Other drugs received by patient: Almeta; Aldactone; Famotidine; SM; Elieten; Lasix; Gosha-Jinki-GAN; Acardi; Solon; NU-Lotan; Bezatol SR; Uralyt-U; Restamin; Transamin; Hustagin; Meiact; Mohrus Tape; Urepearl; Nitropen; Buscopan; Epadel S; Frandol S; Antibiotic Preparations Acting Mainly ON Gram Positive BA
Adverse event in 20 year old male receiving Allegra (Fexofenadine)
Reported by a physician from Japan on 2007-07-31
Patient: 20 year old male
Adverse reactions / side effects: Hepatic Function Abnormal
Adverse event resulted in: hospitalization
Suspect drug(s):
Allegra
Administration route: Oral
Celtect
Adverse event in 35 year old female receiving Allegra (Fexofenadine)
Reported by a physician from Japan on 2007-07-26
Patient: 35 year old female, weighing 51.0 kg (112.2 pounds)
Adverse reactions / side effects: Jaundice, Liver Disorder
Adverse event resulted in: hospitalization
Suspect drug(s):
Allegra (Fexofenadine)
Other drugs received by patient: Meiact; Selbex; Podonin S; Nauzelin
Adverse event in 12 year old female receiving Allegra (Fexofenadine)
Reported by a physician from Japan on 2007-07-25
Patient: 12 year old female, weighing 40.0 kg (88.0 pounds)
Adverse reactions / side effects: Tonic Convulsion, Disorientation, Altered State of Consciousness
Adverse event resulted in: hospitalization
Suspect drug(s):
Allegra (Fexofenadine)
Other drugs received by patient: Depakene / 00228502 /; Phenobal / 00023201 /
Adverse event in male receiving Allegra (Fexofenadine)
Reported by a physician from United States on 2007-07-25
Patient: male, weighing 82.6 kg (181.7 pounds)
Adverse reactions / side effects: Chronic Fatigue Syndrome, Colonic Polyp, Hungry Bone Syndrome, Dyspepsia, Arteriosclerosis, Autonomic Nervous System Imbalance, Hypothermia, Osteopenia, Nasal Congestion, Diverticulum, Sleep Disorder, Left Atrial Dilatation, Nasal Cyst, Thyroid Neoplasm, Sleep Apnoea Syndrome, Atelectasis, Nasal Turbinate Hypertrophy, Vasomotor Rhinitis, Myalgia, Weight Increased, Exostosis, Hypersomnia, Renal Disorder, Bone Lesion, Haemorrhoids, Dental Caries, Rhinorrhoea, Cognitive Disorder, Arrhythmia, Parathyroid Tumour Benign, Spinal Osteoarthritis, Drug Dependence
Adverse event resulted in: hospitalization
Suspect drug(s):
Xalatan
Indication: Glaucoma
Lipitor
Indication: Hypercholesterolaemia
Start date: 2006-01-01
Dextroamphetamine Sulfate
Allegra
Dosage: daily dose:180mg
Astelin
Indication: Rhinitis
Start date: 1994-01-01
End date: 2007-06-28
Propofol
Other drugs received by patient: Synthroid; Vitamin D3; Aspirin; Thyroxin; Hepatitis B Vaccine; Levothyroxine Sodium; Dextroamphetamine Sulfate; Methylphenidate HCL; Ascorbic Acid; Vitamin B; Vitamin CAP; Calcium Chloride; Coffee; Atrovent; Nasalcrom; Montelukast Sodium; Sudafed 12 Hour; Oxymetazoline Hydrochloride; Levopropylhexedrine; Zocor; Zetia; Mevacor; ALL Other Therapeutic Products
Adverse event in receiving Allegra (Fexofenadine)
Reported by a physician from Japan on 2007-07-23
Patient:
Adverse reactions / side effects: Hepatic Function Abnormal
Adverse event resulted in: hospitalization
Suspect drug(s):
Allegra
Administration route: Oral
Celtect
Adverse event in 51 year old female receiving Allegra (Fexofenadine)
Reported by a physician from Japan on 2007-07-06
Patient: 51 year old female, weighing 46.0 kg (101.2 pounds)
Adverse reactions / side effects: Hepatic Function Abnormal, C-Reactive Protein Increased, Pyrexia, White Blood Cell Count Increased, Hepatocellular Damage
Adverse event resulted in: hospitalization
Suspect drug(s):
Allegra (Fexofenadine)
Other drugs received by patient: Rinderon / 00008501 /; Hirudoid / 00723701 /
Adverse event in 12 year old female receiving Allegra (Fexofenadine)
Reported by a physician from Japan on 2007-07-05
Patient: 12 year old female, weighing 40.0 kg (88.0 pounds)
Adverse reactions / side effects: Tonic Convulsion, Disorientation, Altered State of Consciousness
Adverse event resulted in: hospitalization
Suspect drug(s):
Allegra (Fexofenadine)
Other drugs received by patient: Depakene / 00228502 /; Phenobal / 00023201 /
Adverse event in 51 year old female receiving Allegra (Fexofenadine)
Reported by a physician from Japan on 2007-06-25
Patient: 51 year old female, weighing 46.0 kg (101.2 pounds)
Adverse reactions / side effects: Hepatic Function Abnormal, Pyrexia, Hepatocellular Damage
Adverse event resulted in: hospitalization
Suspect drug(s):
Allegra (Fexofenadine)
Other drugs received by patient: Rinderon / 00008501 /; Hirudoid / 00723701 /
Adverse event in 51 year old female receiving Allegra (Fexofenadine)
Reported by a physician from Japan on 2007-06-08
Patient: 51 year old female
Adverse reactions / side effects: C-Reactive Protein Increased, Aspartate Aminotransferase Increased, Alanine Aminotransferase Increased, Pyrexia
Adverse event resulted in: hospitalization
Suspect drug(s):
Allegra (Fexofenadine)
Other drugs received by patient: Rinderon / 00008501 /
Adverse event in 35 year old female receiving Allegra (Fexofenadine)
Reported by a physician from Japan on 2007-05-01
Patient: 35 year old female, weighing 51.0 kg (112.2 pounds)
Adverse reactions / side effects: Jaundice, Liver Disorder
Adverse event resulted in: hospitalization
Suspect drug(s):
Allegra (Fexofenadine)
Other drugs received by patient: Meiact; Selbex; Podonin S; Nauzelin
Adverse event in male receiving Allegra (Fexofenadine)
Reported by a physician from Japan on 2007-04-30
Patient: male, weighing 57.0 kg (125.4 pounds)
Adverse reactions / side effects: Pruritus, Anaemia, Antineutrophil Cytoplasmic Antibody Positive, Vasculitis, Glomerulonephritis Rapidly Progressive, Leukopenia
Adverse event resulted in: life threatening event, hospitalization, disablity
Suspect drug(s):
Hyzaar
Administration route: Oral
Indication: Hypertension
Start date: 2006-12-25
End date: 2007-02-21
Urinorm
Administration route: Oral
Indication: Hyperuricaemia
Start date: 2006-12-25
End date: 2007-02-21
Olmetec
Administration route: Oral
Indication: Hypertension
Start date: 2007-02-22
End date: 2007-03-07
Salobel
Administration route: Oral
Indication: Hyperuricaemia
Start date: 2007-02-22
End date: 2007-03-07
Allegra
Administration route: Oral
Indication: Pruritus
Start date: 2007-02-22
End date: 2007-03-07
Depas
Administration route: Oral
Indication: Pruritus
Start date: 2007-02-22
End date: 2007-03-07
Adverse event in 35 year old female receiving Allegra (Fexofenadine)
Reported by a physician from Japan on 2007-04-26
Patient: 35 year old female, weighing 51.0 kg (112.2 pounds)
Adverse reactions / side effects: Jaundice, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Gamma-Glutamyltransferase Increased, Blood Lactate Dehydrogenase Increased, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Streptococcal Infection, Liver Disorder
Adverse event resulted in: hospitalization
Suspect drug(s):
Allegra (Fexofenadine)
Other drugs received by patient: Meiact; Selbex; Podonin S; Nauzelin
Adverse event in 39 year old female receiving Allegra (Fexofenadine)
Reported by a physician from Japan on 2007-04-19
Patient: 39 year old female, weighing 45.0 kg (99.0 pounds)
Adverse reactions / side effects: Stevens-Johnson Syndrome
Adverse event resulted in: hospitalization
Suspect drug(s):
Allegra
Administration route: Oral
Indication: Rhinitis Allergic
Start date: 2006-11-01
End date: 2007-01-04
Yutan-EN
Administration route: Oral
Indication: Constipation
Start date: 2006-12-01
End date: 2007-01-04
Adverse event in female receiving Allegra (Fexofenadine)
Reported by a physician from Japan on 2007-04-12
Patient: female
Adverse reactions / side effects: Jaundice
Adverse event resulted in: hospitalization
Suspect drug(s):
Allegra (Fexofenadine)
Adverse event in male receiving Allegra (Fexofenadine)
Reported by a physician from Japan on 2007-04-12
Patient: male, weighing 57.0 kg (125.4 pounds)
Adverse reactions / side effects: Anaemia, Glomerulonephritis Rapidly Progressive
Adverse event resulted in: life threatening event, hospitalization, disablity
Suspect drug(s):
Hyzaar
Administration route: Oral
Indication: Hypertension
Start date: 2006-12-25
End date: 2007-02-21
Urinorm
Administration route: Oral
Indication: Hyperuricaemia
Start date: 2006-12-25
End date: 2007-02-21
Olmetec
Administration route: Oral
Indication: Hypertension
Start date: 2007-02-22
End date: 2007-03-07
Salobel
Administration route: Oral
Indication: Hyperuricaemia
Start date: 2007-02-22
End date: 2007-03-07
Allegra
Administration route: Oral
Indication: Pruritus
Start date: 2007-02-22
End date: 2007-03-07
Depas
Administration route: Oral
Indication: Pruritus
Start date: 2007-02-22
End date: 2007-03-07
Adverse event in 39 year old female receiving Allegra (Fexofenadine)
Reported by a physician from Japan on 2007-04-10
Patient: 39 year old female, weighing 45.0 kg (99.0 pounds)
Adverse reactions / side effects: Stevens-Johnson Syndrome
Adverse event resulted in: hospitalization
Suspect drug(s):
Allegra
Administration route: Oral
Indication: Rhinitis Allergic
Start date: 2006-11-01
End date: 2007-01-04
Yutan-EN
Administration route: Oral
Indication: Constipation
Start date: 2006-12-01
End date: 2007-01-04
Adverse event in 66 year old male receiving Allegra (Fexofenadine)
Reported by a pharmacist from Japan on 2007-03-27
Patient: 66 year old male
Adverse reactions / side effects: Speech Disorder, Cerebral Infarction
Adverse event resulted in: hospitalization
Suspect drug(s):
Allegra (Fexofenadine)
Other drugs received by patient: Tamiflu; Aspirin; Ketoten
Adverse event in 75 year old male receiving Allegra (Fexofenadine)
Reported by a pharmacist from Japan on 2007-03-22
Patient: 75 year old male
Adverse reactions / side effects: White Blood Cell Count Decreased
Adverse event resulted in: hospitalization
Suspect drug(s):
Allegra (Fexofenadine)
Other drugs received by patient: Sennoside
Adverse event in 34 year old male receiving Allegra (Fexofenadine)
Reported by a physician from Japan on 2007-01-26
Patient: 34 year old male, weighing 65.0 kg (143.0 pounds)
Adverse reactions / side effects: Hepatic Function Abnormal
Adverse event resulted in: hospitalization
Suspect drug(s):
Allegra
Indication: Dermatitis Atopic
Start date: 2006-03-01
End date: 2006-06-01
Allegra
Administration route: Oral
Start date: 2006-08-01
End date: 2006-12-05
Ourengedokutou
Indication: Dermatitis Atopic
Start date: 2006-03-01
End date: 2006-06-01
Ourengedokutou
Administration route: Oral
Start date: 2006-08-01
End date: 2006-12-05
Adverse event in 40 year old female receiving Allegra (Fexofenadine)
Reported by a physician from Japan on 2007-01-19
Patient: 40 year old female
Adverse reactions / side effects: Stevens-Johnson Syndrome
Adverse event resulted in: hospitalization
Suspect drug(s):
Allegra (Fexofenadine)
Other drugs received by patient: Chinese Herbal Medicine
Adverse event in 79 year old female receiving Allegra (Fexofenadine)
Reported by a physician from Japan on 2007-01-19
Patient: 79 year old female, weighing 42.0 kg (92.4 pounds)
Adverse reactions / side effects: Haemoglobin Decreased, Dyspnoea, Malaise, RED Blood Cell Count Decreased, Platelet Count Decreased, Neutropenia, Lymphocyte Stimulation Test Positive
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Allegra
Administration route: Oral
Indication: Rhinitis
Start date: 2006-11-02
End date: 2006-11-03
Ebastel
Administration route: Oral
Indication: Eczema
Start date: 2006-11-02
End date: 2006-11-05
Zantac
Administration route: Oral
Indication: Gastritis
Start date: 2006-09-19
End date: 2006-11-10
Other drugs received by patient: Prednisolone; Calonal
|
